Health Care: Drugs

Celgene Corp (CELG: NASDAQ)

$111.07 0.09 | 0.08%
11/25/14 - 04:14 PM ET
Company Profile
Price and Volume
Recent Price 110.98
52 Week High 111.00
52 Week Low 66.85
Avg. Daily Vol. (Mil) 4.97
Beta (3 year) 2.02
Share Related Items
Mkt Cap (Mil) 88,640.19
Shares Out (Mil) 798.70
Float (Mil) 798.89
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.70
Current Ratio 6.30
LT Debt/ Equity 1.17
Total Debt / Equity 1.19
Valuation Ratios
Price Earnings 58.10
Price/Sales 12.08
Price/Book 15.37
Price/Cash Flow 44.80
Per Share Data
Earnings 1.91
Sales 9.19
Book Value 7.22
Cash Flow 2.48
Business Summary
Celgene Corp is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
General Information
86 Morris Avenue
Summit, NJ 07901
www.celgene.com
Industry : Drugs
Sector: Health Care
Employees: 5100
CEO: Robert J. Hugin
Short Interest
Current Month (Mil) 13.47
Previous Month (Mil) 11.76
Short Interest Ratio (Days) 2.20
Management Effectiveness
Return on Equity 27.70
Return on Assets 9.80
Return on Investments 12.80
Profitability
Gross Margin 96.50
EBIT Margin 27.10
Profit Margin 21.80

Portfolios with CELG

Latest CELG Headlines from TheStreet

More Financial News for CELG

Press Releases for CELG

See All Press Releases

Partner Headlines for CELG

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter